Why the study?
What is the distribution of MR-proANP and its association with cardiovascular risk factors in a general population?
Cross-Sectional (n=5,000)
What is the distribution of MR-proANP and its association with cardiovascular risk factors in a general population?
Answers are grounded in this paper and cite their sources.
The study establishes population-based reference values for MR-proANP, which may aid in risk stratification and distinguishing healthy from diseased individuals.
BACKGROUND: The use of biomarkers is firmly established for the assessment of cardiovascular disease. Emerging biomarkers such as midregional pro-atrial natriuretic peptide (MR-proANP) challenge established markers regarding risk prediction and stratification ability. The aim of the present study was to describe the distribution of a contemporary MR-proANP assay in a large population-representative sample and to evaluate the association with prevalent cardiac diseases and cardiovascular risk factors. METHODS: MR-proANP was determined by the use of a contemporary commercially available assay (BRAHMS GmbH, Hennigsdorf, Germany) in a representative sample of 5000 participants from the large population-based Gutenberg Health Study. N-terminal pro B-type natriuretic peptide (NT-proBNP) was used as a comparator. RESULTS: Mean age was 55.5 ± 10.9 years. Coronary artery disease (CAD) was documented in 4.6%, heart failure (HF) in 1.5% of the study participants. We observed a moderate to strong correlation of the biomarkers with age, diabetes, hypertension, smoking, renal function, prevalence of CAD and HF. Males showed lower MR-proANP concentrations than females. MR-proANP showed no relevant correlation with BMI (ρ=-0.030) and CRP (ρ=0.039). Reference limits for MR-proANP representing the 95th/97.5th/99th percentile were determined for healthy individuals with 116/132/169 pmol/mL. CONCLUSIONS: The current analysis in a large population-based sample elucidates the correlations and distribution of MR-proANP. Its concentration in healthy individuals depends on prevalent cardiovascular diseases and classical risk factors. The reported population-based reference values might be useful for distinguishing between healthy and diseased individuals, thus improving risk stratification and triaging in various clinical settings.
No takes yet. Share an insight, caveat, or question.
Tzikas et al. (2012) conducted a cross-sectional in General population (n=5,000). MR-proANP vs. NT-proBNP was evaluated on Distribution of MR-proANP and association with prevalent cardiac diseases and cardiovascular risk factors.
Synapse has enriched 10 related papers. Consider them for comparative context: